USTR SEEKS COMMENTS ON THE EXTENSION OF CHINA 301 TARIFF EXCLUSIONS ON CERTAIN MEDICAL CARE PRODUCTS
In a Federal Register Notice of August 27, 2021, the Office of the U.S. Trade Representative (“USTR”) announced that it is seeking comments on the extension of existing China 301 exclusions on certain medical care products.
On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending certain expiring China 301 tariff exclusions on medical care products and designating certain additional such exclusions for the period January 1, 2021 through March 31, 2021. Such exclusions (99 in total) were extended through September 30, 2021.
In a win for GDLSK client Triune Technofab Private Limited, the U.S. Department of Commerce recently finalized its antidumping duty investigation of boltless steel shelving units prepackaged for sale from
On April 17, 2024, the United States Trade Representative (USTR) announced that it has initiated an investigation under Section 301 of the Trade Act of 1974 to review China’s acts,
Insights, News
USTR SEEKS COMMENTS ON THE EXTENSION OF CHINA 301 TARIFF EXCLUSIONS ON CERTAIN MEDICAL CARE PRODUCTS
In a Federal Register Notice of August 27, 2021, the Office of the U.S. Trade Representative (“USTR”) announced that it is seeking comments on the extension of existing China 301 exclusions on certain medical care products.
On December 29, 2020, in response to the evolving COVID-19 situation, the USTR had announced that it was extending certain expiring China 301 tariff exclusions on medical care products and designating certain additional such exclusions for the period January 1, 2021 through March 31, 2021. Such exclusions (99 in total) were extended through September 30, 2021.
In light of various factors, including the rise in COVID-19 cases in the U.S. and the ability to obtain certain products from domestic and foreign sources, the USTR is requesting public comments on whether to extend the medical care product exclusions for up to six months. The list of the particular products in question can be found at: https://www.gdlsk.com/ustr-extends-certain-china-301-exclusions-and-designates-additional-exclusions-for-the-period-january-1-march-31-2021/?highlight=medical%20care%20products.
Comments are being accepted through September 27, 2021.
We are available to assist with the preparation of comments and to otherwise discuss China 301 mitigation strategies.
Please do not hesitate to contact Arthur Bodek or any of our attorneys for further information.
Additional News
GDLSK Secures 0% ADD Rate for Triune Technofab Private Limited
In a win for GDLSK client Triune Technofab Private Limited, the U.S. Department of Commerce recently finalized its antidumping duty investigation of boltless steel shelving units prepackaged for sale from
USTR Initiates 301 Investigation on China’s Policies Targeting the Maritime, Logistics, and Shipbuilding Industries
On April 17, 2024, the United States Trade Representative (USTR) announced that it has initiated an investigation under Section 301 of the Trade Act of 1974 to review China’s acts,
Additional Insights
Partner David Murphy to Present at 2024 NAFTZ Spring Seminar
On May 7, 2024, GDLSK partner David M. Murphy will be a featured speaker at the 2024 National Association of
March 2024: Upcoming GDLSK Presentation on Consequences of Updates to the 19 CFR 111 Broker Regulations
Richard Wortman will be presenting an in person educational seminar for the Customs Brokers and Forwarders of Northern California (CBFANC)